How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation. View classification details, related manufacturers, 510(k) clearances, and recall records.
293 clearance records and 240 recall records in the covered releases, across 22 source company names and 1 product codes. Dated history runs from Aug 1, 1986 to Nov 4, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 1 | 0 |
| April 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 3 |
| July 2026 | 0 | 1 |
| August 2026 | 0 | 2 |
| September 2026 | 1 | 0 |
| October 2026 | 1 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| LON · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation | 293 | 240 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH GATIFLOXACIN (0.004-16 UG/ML)K023361 · LON | Dade Behring, Inc. | 510(k) | Dec 16, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH MOXIFLOXACIN (0.004-16UG/ML)K023541 · LON | Dade Behring, Inc. | 510(k) | Dec 13, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK023301 · LON | Becton, Dickinson & CO | 510(k) | Nov 12, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMIKACIN-0.5-64 UG/MLK023444 · LON | Becton, Dickinson & CO | 510(k) | Nov 12, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - GENTAMICIN 0.25 - 16 UG/MLK023273 · LON | Becton, Dickinson & CO | 510(k) | Oct 31, 2002FDA decision date |
| VITEK GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR LINEZOLIDK022045 · LON | bioMerieux, Inc. | 510(k) | Aug 15, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK022172 · LON | Becton, Dickinson & CO | 510(k) | Aug 12, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CLINDAMYCIN 0.125-8.0MCG/MLK021954 · LON | Becton, Dickinson & CO | 510(k) | Aug 1, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM MOXIFLOXACIN 0.125-8 UG/MLK022129 · LON | Becton, Dickinson & CO | 510(k) | Jul 25, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS DRIED GRAM NEGATIVE MIC/COMBO PANELS WITH CEFTAZIDIME (1-16 UG/ML)K020413 · LON | Dade Behring, Inc. | 510(k) | Jul 17, 2002FDA decision date |
| MICROSCAN RAPID/S PLUS GRAM-NEGATIVE MIC/COMBO PANELS WITH CEPHALOTHIN (2-64 UG/ML)K020410 · LON | Dade Behring, Inc. | 510(k) | Jun 11, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK020321 · LON | Becton, Dickinson & CO | 510(k) | May 23, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN (0.25-128 UG/ML)K020398 · LON | Dade Behring, Inc. | 510(k) | May 16, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH PIPERACILLIN (4-256 UG/ML)K020397 · LON | Dade Behring, Inc. | 510(k) | Apr 22, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN/SULBACTAM (0.5/0.25-64/34 UG/ML)K020319 · LON | Dade Behring, Inc. | 510(k) | Apr 17, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM-NEGATIVE MIC/COMBO PANELS WITH CEFTRIAXONE (0.5-128 UG/ML)K020506 · LON | Dade Microscan, Inc. | 510(k) | Apr 17, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK020323 · LON | Becton, Dickinson & CO | 510(k) | Apr 4, 2002FDA decision date |
| VITEK 2 ANTIMIRCROBIAL SUSCEPTIBILITY TEST SYSTEM FOR LEVOFLOXACINK020871 · LON | bioMerieux, Inc. | 510(k) | Mar 29, 2002FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK020322 · LON | Becton, Dickinson & CO | 510(k) | Mar 27, 2002FDA decision date |
| VITEK 2 ANTIMICROBIAL SUSCEPTIBILITY TEST SYTEM FOR SPARFLOXACINK020870 · LON | bioMerieux, Inc. | 510(k) | Mar 25, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUSK020142 · LON | Dade Behring, Inc. | 510(k) | Mar 14, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH TRIMETHOPRIM/SULFAMETHOXAZOLE (0.25/4.75-64/1216 UG/ML)K020248 · LON | Dade Behring, Inc. | 510(k) | Mar 14, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUSK020511 · LON | Dade Microscan, Inc. | 510(k) | Mar 6, 2002FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH CEFUROXIME (1-64 UG/ML)K020328 · LON | Dade Behring, Inc. | 510(k) | Feb 19, 2002FDA decision date |
| MICROSCAN SYNERGIS PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH TOBRAMYCIN (0.12-32 UG/ML)K020168 · LON | Dade Behring, Inc. | 510(k) | Feb 6, 2002FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.